Skip to content

Trillium presents preclinical blood cancer data, enrolling trial patients

April 3, 2017

*Trillium Therapeutics presents TTI-621 preclinical data at AACR annual meeting and provides clinical update

* Trillium Therapeutics-currently enrolling patients in expansion phase of ongoing phase 1 trial of tti-621, in patients with multiple Hematologic malignancies

* Trillium therapeutics inc – to date, 33 evaluable patients have been enrolled into expansion phase of tti-621 trial


From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: